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Abstract
Background: Parkinson’s disease (PD) is a common neurodegenerative condition associated with a wide range
of motor and non-motor symptoms. There has been increasing interest in the potential benefit of performing
arts as a therapeutic medium in PD. While there have been previous reviews, none have considered all
performing arts modalities and most have focused on dance. This systematic review examined the potential
benefit of all active group-based performing arts interventions for quality of life, functional communication,
speech, motor function and cognitive status.
Methods: Searches were conducted in February 2020 on five scholarly databases. Supplementary searches
were conducted. Included studies were quantitative in design, and assessed the potential benefit of any
active group-based performing arts intervention for quality of life, functional communication, speech, motor
function or cognitive status in people with PD. Full text papers were eligible for inclusion, as were conference
abstracts since January 2018. Screening, data extraction, narrative synthesis and quality assessment were
conducted independently by two reviewers. Quality assessment used the SURE checklists.
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Results: Fifty-six studies were eligible for inclusion in this systematic review, reported in 67 publications.
Published from 1989 to 2020, these studies included a total of 1531 people with PD from 12 countries, and
covered four broad performing arts modalities: dance, singing, music therapy and theatre. Dance remains the
most commonly studied performing arts modality for PD (38 studies), while there were 12 studies on singing
interventions, four on music therapy, and only two on theatrical interventions. There was evidence for a
beneficial effect of all four performing arts modalities on at least some outcome domains.
Conclusions: This is the first systematic review to assess the potential benefit of all active group-based
performing arts interventions in PD. The evidence suggests that performing arts may be a useful therapeutic
medium in PD. However, a substantial limitation of the evidence base is that no studies compared
interventions from different performing arts modalities. Moreover, not all performing arts modalities were
assessed for all outcome domains. Therefore it is not currently possible to determine which performing arts
modalities are most beneficial for which specific outcomes.
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Background
Parkinson’s disease
Parkinson’s disease (PD) is an age-related neurodegenera-
tive condition that can affect movement and motor control
[1] as well as present with a wide range of non-motor
symptoms [2] including cognitive impairment. Speech and
communication difficulties are common in PD [3] and may
result from a combination of motor and non-motor factors
[4]. PD is one of the most common neurodegenerative
conditions with 6.1 million people worldwide estimated to
have PD in 2016 [5] with the prevalence expected to rise
with the global ageing population [6]. The precise aetiology
of PD remains unknown. However, it is known that the
pathogenesis of PD, in particular cognitive functioning,
involves the cholinergic, [7] serotonergic [8] and noradren-
ergic [9] systems, as well as the dopamine system which
was historically seen as the sole system implicated in PD
neuropathology [10]. The impact of PD on the quality of
life of individuals can be substantial [11, 12]. Moreover,
there can be substantial caregiver burden, [13] which may
result in part from the combination of motor and non-
motor symptoms and from communication difficulties.
There is also a high social and economic impact of PD: for
example, between 1994 and 2013 the mean annual health
care cost difference in the UK between individuals with PD
and controls was £2471 per annum per person at 2013
costs, increasing to £4004 10 years after diagnosis [14].
Treatments for Parkinson’s disease
In recent decades, levodopa-based pharmacotherapy has
become the mainstay of treatment for PD, demonstrat-
ing good efficacy in targeting motor symptomatology
[15, 16]. However, dyskinesia – impairment of voluntary
movement – as a side-effect is a substantial drawback to
this treatment regimen [17]. Also, there is a lack of
reliable evidence of benefit on speech [18, 19] and non-
motor symptoms including cognition. These limitations
of available pharmacotherapy regimens have led to in-
creasing interest in non-pharmacological interventions
in PD. There has been interest in how a wide range of
allied health approaches may help address a wider range
of PD symptoms. Exercise is a therapeutic modality that
may be effective for PD, including for cognitive symp-
toms [20]. Speech and language therapy (SLT), in
various forms, has been a popular approach to seek to
address the speech and communication difficulties asso-
ciated with PD. However, the robustness of the evidence
base for current SLT approaches in PD remains prob-
lematic with one structured narrative review [20] and
one Cochrane systematic review [21] finding no reliable
evidence of significant benefit, and one systematic review
[22] finding some evidence of benefit in limited areas of
motoric speech production. The potential challenges
facing SLT in PD are multifaceted, but one challenge
identified in the United Kingdom is a traditional ten-
dency for therapeutic techniques to focus largely on
motoric aspects of speech production at the expense of
functional communication, [23] whereas people with PD
have reported social isolation resulting from functional
communication difficulties to be much more burdensome
than motoric speech impairment, [24] suggesting a
misalignment of priorities. It should be noted that SLT ap-
proaches to PD differ internationally with the Lee Silver-
man Voice Therapy method [25] being standard clinical
practice in some health systems. The difficulties encoun-
tered by SLT in PD have led to increased interest in a
broader range of interventions that may provide benefit to
different aspects of the PD symptom profile, including
through everyday activities. Since social isolation plays such
a key role in driving poor quality of life in PD – social isola-
tion is for example a domain of the Nottingham Health
Profile [26] and difficulties in this domain were reported by
the majority of people with PD [27] – a broader range of
interventions that increase social contact may be beneficial.
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Performing arts as therapy for Parkinson’s disease
The performing arts are a therapeutic modality in which
there has been increasing interest, including in neuro-
logical conditions such as PD. Participation in the
performing arts has been demonstrated to bring a range
of psychosocial and health-related benefits in the general
population as well as a wide range of diseases [28]. The
identified benefits of performing arts can be broadly sub-
divided into instrumental and intrinsic benefits. Identi-
fied instrumental benefits of the performing arts include
cognitive, attitudinal and behavioural and health benefits
at the individual level as well as social and economic
benefits at the community level. Additionally, the arts
broaden and deepen an individual’s understanding of the
world, [29] while there is evidence [30] that choral sing-
ing may offer social and mental health benefits to disad-
vantaged adults at personal, social and functional levels.
One interesting aspect of the findings is how forming a
new group identity as a choir member was associated
with emotional and health benefits, consistent with
social identity theory [31]. The intrinsic benefits of the
arts [28] relate to ways in which effects intrinsic in the
arts experience add value to people’s lives and are a
valuable contribution of the arts, although they can be
intangible and difficult to define. The methodological
limitations of the field notwithstanding, performing arts
appear to offer promise as a therapeutic medium that
may increase social contact, reduce social isolation, offer
the uptake of new activities or the maintenance of pre-
diagnosis activities and offer interventions that are relatively
familiar to many people, including through exposure
to popular performing arts competition shows on
television – after all media, culture and society are
closely interwoven [32].
Previous literature reviews
Previous literature reviews on performing arts therapies
for PD have focused largely on dance. Among recent ef-
forts related to dance, systematic reviews of randomised
controlled trials have shown a benefit on executive func-
tion [33] as well as motor symptoms and functional mo-
bility, [34] while a systematic review of a broader range
of studies [35] found that dance may have the potential
to improve PD symptoms, particularly gait, global cogni-
tion and cognitive dual-tasking. There have been few
published syntheses of the evidence relating to other
performing arts modalities. One published systematic
review has examined singing as a therapeutic modality
in PD, conducted by our team, [36] and found evidence
of benefit for speech, although all studies used a single-
group repeated-measures design. A potential benefit of
music therapy on gait in people with PD has been sug-
gested by a systematic review, [37] although the music
therapy interventions studied were not participatory. A
non-systematic review [38] has however shown a benefit
of instrument playing for PD, although this is limited by
the non-systematic nature of the review. No review of
theatrical interventions for PD has been published to
our knowledge. There has been no systematic review
assessing a full range of artistic modalities, precluding a
truly comparative evaluation across modalities. This
provides the rationale for conducting a new systematic
review as presented in this manuscript.
The present review
The current review sought to synthesise evidence relat-
ing to the clinical effectiveness of a broad range of
performing arts modalities in PD in order to provide a
comparative perspective not offered by existing reviews.
Therefore, it was decided to narrow the focus to active
participation interventions delivered in a group setting.
Active participation excludes purely passive performing
arts related activities such as listening to music, watch-
ing dancing or watching theatrical performances, and it
is active participation that has been identified as having
the power to alleviate behavioural and psychological
symptoms as well as to benefit communication and rela-
tionships [39]. Furthermore, only group interventions
were considered because these were considered most
likely to address social challenges that have been shown
to be important in PD. [27] The review was limited to
clinical effectiveness on a set of five key outcome domains
used in a previous review of singing in PD [36] – quality
of life, speech, functional communication, motor function
and cognitive status – as opposed to cost effectiveness or
patient experience, for reasons of feasibility. The current
review sought to answer the following questions:
1. What impact does group performing arts therapy,
with active participation, have on the following
outcomes for people with PD: quality of life, speech,
functional communication, cognitive status or
motor function?
2. Is there a difference in impact on these outcomes
according to which performing arts modality is
used?
It is only by considering all available active group-
based performing arts interventions that a clear picture
of the benefit of performing arts for PD can be ascer-
tained. Offering this comparative perspective is the key
step forward in knowledge offered by our manuscript.
Methods
This review was conducted in accordance with PRISMA
guidelines. The review was not pre-registered.
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Search strategy
Systematic searches were conducted in February 2020 using
PsycINFO (Ovid), AMED (Ebsco), CINAHL (Ebsco),
EMBASE (Ovid) and MEDLINE (Ovid). The published
search strategy from a prior review of singing in PD [36]
was expanded to encompass other performing arts modal-
ities. The search strategy was developed in MEDLINE
(Table 1) and translated for all other databases. Supplemen-
tary searches were conducted on Google Scholar and by
screening reference lists of relevant retrieved articles.
Forward and backward citation chasing were conducted on
relevant reviews as well as studies identified for full-text
screening. The results from each search were initially
reviewed separately at the title and abstract stage. Those
that appeared to meet the inclusion criteria were de-dupli-
cated and combined. Initial full-text screening was
performed based on language, article type and broad
methodology. Then, detailed full-text screening was
performed on all articles that remained in order to
determine final inclusion. All screening procedures
were performed independently by two persons.
Selection criteria
Studies were included in the review if 1) they looked at a
performing arts intervention, 2) they assessed clinical
effectiveness related to speech, functional communica-
tion, cognitive status, motor function or quality of life
using any quantitative design, 3) the intervention offered
an opportunity for active participation as opposed to
passive appreciation, 4) they looked at group rather than
individual interventions, 5) participants were people with
a diagnosis of PD, and 6) they were published in a peer-
reviewed journal in English (no date limit) or were
published as an English-language conference abstract
since January 2018.
Data extraction and analysis
Data extracted from each study included study charac-
teristics (Additional file 1: Appendix 1) – country, de-
sign, participants, inclusion criteria, and outcomes;
intervention profile (Additional file 1: Appendix 2) –
content, leader, location and duration of performing arts
intervention; control profile (Additional file 1: Appendix
3) as well as results (Additional file 1: Appendix 4). All
data extraction was performed independently by two
persons using standardised forms, and any disagree-
ments resolved by discussion. There was substantial
methodological and clinical heterogeneity, including
with regard to recruitment, settings, nature of the per-
forming arts intervention, nature of the control arm and
the assessment tools used for outcome measures. There-
fore, thematic narrative synthesis was used as the pri-
mary analysis method. Additionally, random effects
meta-analysis was performed for combinations of key
scale outcomes (from UPDRS motor and TUG for motor
function, MMSE, FAB and MoCA for cognitive function,
and PDQ-39 total score for patient QoL) and interven-
tions for which there were at least two studies using a
common comparator. Review Manager version 5.3 soft-
ware (Cochrane Collaboration) was used. In terms of
performing arts interventions, singing, music therapy
and theatrical interventions were assessed as unitary cat-
egories in this comparison. However, due to the wide
variety of dance forms assessed by studies, we formed
two categories 1) PD-specific dance forms and 2) tango
or adapted tango, which were the two most common
types of dance used in the studies. Outcomes were con-
tinuous and meta-analyses were conducted on mean dif-
ference between final follow-up and baseline (change
score) where this information plus a measure of variabil-
ity that could be converted to standard deviation was
provided. If this information was not provided, meta-
analyses were conducted on the scores at the final
follow-up point. As the meta-analysis was a secondary
analysis, there were no sensitivity or subgroup analyses,
and risk of bias was considered at the level of the indi-
vidual study, as outlined below. Forest plots are provided
in Additional file 1: Appendix 7, Part C.
Quality appraisal
All studies were quantitative, although they encompassed a
variety of methods including randomised controlled trials,
randomised trials with two intervention groups but no con-
trol group, non-randomised controlled trials, and single
group repeated measures studies. In order to address the
variation in designs, the Specialist Unit for Review Evidence
(SURE) critical appraisal checklists (https://www.cardiff.ac.
uk/specialist-unit-for-review-evidence/resources/critical-ap
praisal-checklists) were used. Previously used in evidence
synthesis for performing arts interventions, [40] SURE is
adapted from the Health Evidence Bulletins Wales check-
list, the National Institute for Health and Care Excellence
Public Health Methods Manual and the Critical Appraisal
Skills Programme checklists. All versions of SURE ask
similar questions, but are tailored to the specific study
methodology. The SURE Experimental Studies Critical
Appraisal Checklist was used for all trials, while the SURE
Cohort Studies Critical Appraisal Checklist was used for
longitudinal observational studies, such as single group
repeated measures designs. SURE benefits from offering an
in-depth appraisal rather than relying on a summary score,
which may not provide an adequate assessment of
Table 1 MEDLINE search strategy
“exp Parkinson disease/ AND singing.mp OR exp. Singing/ OR music.mp
OR exp. Music/ OR music therapy.mp OR exp. Music therapy/ OR
dance.mp OR dancing.mp OR exp. Dancing/ OR drama.mp OR exp.
Drama/ OR theatre.mp OR theater.mp OR theatrical.mp OR performing
art*.mp OR art OR arts or exp. Art/ OR art therapy.mp OR exp. Art therapy/”
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limitations specific to the individual study [41]. Quality ap-
praisal was conducted independently by two persons and
was conducted at the study level. It was not possible to con-
duct quality appraisal for studies for which only conference
abstracts were available due to insufficient information to
conduct robust assessment. The results of the critique are
shown in Additional file 1: Appendices 5 and 6. The results
of the quality assessment were used to inform the interpret-
ation and discussion of the findings.
Results
The study selection process resulted in the inclusion of
56 studies (reported in 67 separate publications) that
met the inclusion criteria for the systematic review, of
which 10 were able to provide data for the meta-analysis
(see Fig. 1 for details of each stage in the process and
reasons for exclusion). Studies came from 12 countries
(Australia, Canada, Germany, Italy, Ireland, Japan, New
Zealand, Norway, South Korea, Sweden, the UK, and the
USA) and used a variety of quantitative designs. They
were published from 1989 to 2020 and involved a total
of 1531 participants with PD (sample size from one study
not available); the number of participants ranged from 5
to 95 per study (median sample size 22). Studies covered
four broad performing arts modalities: dance, music
therapy, singing, and theatre. Music therapy was concep-
tualised as active interventions of a musical nature that
did not solely involve singing. A full list of included
studies is provided in Additional file 1: Appendix 8.
Theatre was the performing arts modality that was
least studied with only two included studies [42, 43].
Both studies compared theatrical interventions led by
professional performers to physiotherapy. Both studies
were Italian, while one [43] randomised group allocation.
In the other study [42], allocation to groups was deter-
mined by logistics rather than randomisation.
There were four studies assessing music therapy.
Within this modality, each study was quite different in
the music therapy intervention offered. Pohl et al. [44]
assessed the Ronnie Gardiner Rhythm and Music
Method (RGMM) comprising musical exercises to
challenge cognition and sensorimotor control. Spina
et al. [45] used an intervention that comprised musical
exercises, singing and dancing, showing that interven-
tions can draw on components of multiple performing
arts. Pacchetti et al. [46] assessed the benefit of instru-
mental musical improvisation. Pantelyat et al. [47]
considered a West African drum circle intervention and
was the only music therapy study to not be randomised.
Three studies compared music therapy to usual care,
while the control in Pacchetti et al. [46] was a physio-
therapy intervention.
There were 12 studies assessing singing interventions.
Studies differed in the details of the intervention, but
were all choral-based singing interventions. It was
notable that the study by Tamplin et al. [48, 49] also in-
cluded morning or afternoon tea for social interaction
and conversation practice, which was offered to both
intervention and control participants. Notably, in this
study, the intervention was offered in weekly and monthly
versions and the weekly and monthly singing groups dif-
fered in terms of having professional and amateur leaders
respectively and whether the control group was a weekly
activity such as painting, dancing or tai chi, or a monthly
peer support group. Only two singing studies included a
control group and the only randomised controlled trial
was by Matthews et al., [50] in which the control group
undertook a passive music appreciation activity.
Fig. 1 PRISMA flow chart for study selection
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As expected, given the greater focus on dance rather
other performing art forms in previous reviews, dance
was the performing arts therapeutic medium for which
there was the largest body of evidence with a total of 38
studies (see Additional file 1: Appendix 1 for details of
each study). Twenty-two of these dance studies included
a control group: variously physiotherapy, [51] exercise,
[52–58] education, [59–61] support groups, [62, 63]
usual care, [55, 64–77] and a waiting list control [78]. Of
these, there were 14 separate randomised controlled trials
[51, 53–55, 57, 59, 61–70, 72, 75, 78, 79]. Across the 39
dance studies, a number of different dance styles were
used. These could be broadly classified into PD-specific
dance forms, such as the Dance for Parkinson’s Disease
method as designed by the Mark Morris Dance Group
and the Brooklyn Parkinson Group, [80] modern dance
including improvisational dance forms, mixed-genre
dance, Turo dance (based on Qi meridians), ballet, Irish
set dancing, Ballu Sardu (a Sardinian folk dance) and
tango (see Additional file 1: Appendix 2 for details on
dance styles used in each study). Two separate forms of
tango were used – traditional Argentine tango and
adapted tango, the latter adapting steps for people with
PD. Traditionally, in tango, the lead role is danced by the
male. In adapted tango, typically all participants danced
both lead and follow roles, while some studies of Argen-
tine tango also adopted this practice. It was noted that in
the single group repeated measures study by Koch et al.
[81] on Argentine tango, there were three separate group
workshops (with each participant attending one) and in
the first workshop, the class was taught in English and
translated into German, whereas the other two workshops
had a different leader and were taught directly in German.
Methodological limitations were frequent and SURE
analysis (Additional file 1: Appendices 5 and 6) highlights
that common limitations included sampling, allocation
methods and absence of control groups. The discussion re-
flects on these methodological issues and their implications.
Narrative synthesis of outcomes for people with
Parkinson’s disease
Quality of life
Twenty-two studies assessed the impact of dance inter-
ventions on quality of life (Additional file 1: Appendix
4), of which nine were randomised and eight had no
control group. The most common dance interventions
were PD-specific dance forms (9 studies) and tango or
tango-based interventions (9 studies). Turo, Irish set
dancing, American Ballroom and mixed-style partnered
dance were all also studied. Across studies, the balance
of the evidence supported a benefit of dance for quality
of life, and this supported chiefly PD-specific and tango
or tango-based dance forms, as these had been studied
most. Only one study assessed American Ballroom [67–
69] and found no evidence of significant benefit on qual-
ity of life. One study [59] found that following in tango
offered greater quality of life benefit than leading. Four
studies considered the impact of music therapy interven-
tions on quality of life. Compared to usual care, Pante-
lyat et al. [47] found a beneficial effect of the drum
circle, while Pohl et al. [44] found the same for RGRM
M, as did Spina et al. [45] Compared to physiotherapy,
Pacchetti et al. [46] found a beneficial effect of instru-
mental musical improvisation on health-related quality
of life. Four studies assessed the impact of a singing
intervention on quality of life [48–50, 82–85]. Of these,
Matthews et al. [50] used a RCT design compared to a
passive music appreciation activity, while Tamplin et al.
[48, 49] used a non-randomised controlled trial design with
various comparators, the limitations of which were dis-
cussed above. Studies differed as to what aspects of quality
of life they assessed and how these were measured. General
quality of life was assessed by three studies. Both Irons
et al. [82, 83] and Matthews et al. [50] used the Parkinson’s
Disease Questionnaire 39 Items (PDQ-39), [86], while Ste-
gemöller et al. [84, 85] used the World Health Organization
Quality of Life questionnaire (WHO-QOL) [87]. Voice-
related quality of life (VRQoL) [88] was assessed by two
studies [48, 49, 84, 85]. Additionally, Stegemöller et al. [84,
85] assessed swallow-related quality of life (SWAL-QOL),
[89] although no significant effect was found on this out-
come. Two studies considered the impact of theatrical in-
terventions on quality of life. Mirabella et al. [42] and
Modugno et al. [43] both found group theatrical interven-
tions led by professional performers to be more effective
than physiotherapy in improving overall health-related
quality of life. Mirabella et al. [42] additionally found a
greater benefit on emotional wellbeing.
Speech
Of the 12 studies considering singing interventions, 11
assessed speech outcomes. The body of evidence across
studies (Additional file 1: Appendix 4) supports a benefit
of group singing on speech, with only one study [90]
finding no evidence of benefit. However, statistical sig-
nificance was not always reached likely as a result of
small sample sizes. Speech outcomes for which there
may be benefit of group singing interventions include
phonation, intelligibility and vocal intensity, although
the precise patterning of speech features for which evi-
dence of benefit was found differed between studies.
Only Tanner et al. [91] reported clinical significance,
and clinically significant improvements were found for
intensity range in read speech and fundamental fre-
quency variation, while the improvement in fundamental
frequency in read speech was possibly clinically signifi-
cant. Only two studies included a non-singing control
group. In an RCT, Matthews et al. [50] compared a
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singing intervention to a passive music appreciation ac-
tivity and found evidence of a significant benefit on
phonatory measures. In a non-randomised controlled
trial, Tamplin et al. [48, 49] compared weekly and
monthly singing interventions to a weekly session of
painting, dancing or tai chi or a monthly per support
group, and found that singing significantly improved
speech intensity but not phonation, while a greater bene-
fit was found in the weekly group. It should be noted
that the weekly singing intervention was delivered by a
professional music therapist and the monthly singing
intervention was delivered by recreational local musi-
cians, which further complicates interpretation of the
findings, since it is unclear whether it is weekly delivery
or a professional teacher that drives the benefit. More-
over, both the intervention and control groups also
attended a morning or afternoon tea alongside each ses-
sion for socialising and conversational practice. No stud-
ies considered the impact of any other performing arts
modalities besides singing on speech.
Functional communication
Two studies discussed the impact of singing interventions
on functional communication. Shih et al. [90] found no
significant change in functional communication after a
group singing intervention of one 90-min session per
week for 12 weeks. However, a study by Elefant et al. [92,
93] found that a group singing intervention of one 60-min
session per week for 20 weeks significantly improved com-
municative facial expression and physical communication,
although improvements in overall communication, plus
functional and emotional subscales did not reach statis-
tical significance. Neither study included a control group,
which is a substantial limitation in terms of interpreting
any observed benefit. No studies considered the impact of
any other performing arts modalities besides singing on
functional communication.
Cognitive status
Ten studies considered the impact of dance interven-
tions on cognitive status (Additional file 1: Appendix 4),
of which six were randomised and only one study [94]
did not have a control group. The evidence sub-divides
into PD-specific dance forms (5 studies), tango, either
Argentine or adapted (4 studies) and Ballu Sardu (1
study). At least some evidence of benefit on cognition
was found for all studies across both dance styles, except
one study on PD-specific individually customised dance
[62, 63]. One study [59] compared leading and following
tango, and found that participants assigned to follow
(this was not based on gender) improved significantly
more in cognition than participants assigned to lead.
Three studies considered the impact of music therapy
interventions on cognitive status. Pohl et al. [44] found a
benefit of the RGRMM on cognitive function, while
Spina et al. [45] found the same with an active music
therapy intervention comprising music, singing, and
dancing. However, Pantelyat et al. [47] did not find evi-
dence of a beneficial effect of a West African drum circle
intervention on cognition. Among these three studies, all
included a control group and in each case the control
group was usual care. The studies by Pohl et al. [44] and
Spina et al. [45] were both randomised. No studies con-
sidered the impact of singing interventions on cognitive
status, although one study [82, 83] considered a cogni-
tive quality of life subscale, which was considered a qual-
ity of life measure. One study [42] considered the impact
of theatrical interventions on cognitive status and found
no evidence of improvement in either the intervention or
the physiotherapy control group. It used a non-
randomised controlled trial design.
Motor function
Thirty-one studies considered the impact of dance inter-
ventions on motor function, of which 16 were rando-
mised and eight lacked a control group (single group
designs). The most common dance interventions were
tango or tango-based dance (13 studies) and PD-specific
dance forms (6 studies). Modern dance, improvisational
dance, American Ballroom, mixed-genre or various part-
nered dance, ballet, turo, Irish set dancing, Ballu Sardu
and dance/movement therapy were all also studied.
Across studies, the balance of evidence supported a
benefit of dancing for improving motor function, with
the greatest volume of evidence being for tango and
tango-related dance as well as PD-specific dance forms.
One study [59] compared leading and following in tango
and found that generally following was significantly
motor effective than leading for improving motor func-
tion, although the opposite finding was found specifically
for medication-related motor fluctuations. Only one
study [95] considered clinical significance and found that
the statistically significant benefit in motor function as-
sociated with improvisational dance fell slightly short of
clinical significance. Four studies considered the impact
of music therapy interventions on motor function. One
study compared instrumental music improvisation to
physiotherapy [46] and found that music therapy was
more effective for improving motor function. RGRMM
was found to be more effective than usual care for motor
function, [44] while the evidence for a benefit of the
drum circle on motor function was not conclusive [47]
and no evidence of a benefit of the Spina et al. [45]
music therapy intervention was found for motor func-
tion. One study considered the impact of a singing inter-
vention on motor function. Using a design without a
control group, but with high and low dosage interven-
tion groups, which were allocated according to clinical
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and logistical factors rather than randomly, Stegemöller
et al. [84, 85] found a benefit of a weekly group singing
session for 8 weeks on the motor subscale of the Unified
Parkinson’s Disease Rating Scale (UPDRS) [96]. Two
studies considered the impact of theatrical interventions
on motor function. Both compared to physiotherapy,
one study [43] found evidence of a beneficial effect of
theatre on motor function, while the other [42] did not.
Main methodological concerns
The main methodological concerns that were applicable
to the body of evidence as a whole included small sample
sizes, the absence of control groups in over half of the in-
cluded studies (this was not an issue for the music therapy
and theatrical studies, but was common in dance studies,
and very common in singing studies), considerable
variation in the frequency and duration of intervention de-
livery, a wide range of disciplinary backgrounds and levels
of experience among session leaders, substantial hetero-
geneity of outcome measures, especially for cognition but
also for motor function, as well as a focus on statistical ra-
ther than clinical significance. These issues are discussed
in detail in the discussion section.
Different performing arts modalities
No studies directly compared different performing arts
modalities. Studies assessing each performing arts
modality were conducted by different research teams,
suggesting a tendency for scholars to work on a specific
performing art modality rather than undertake multi-
disciplinary research across dance, music therapy, sing-
ing, and/or theatre. Not all of the outcomes of interest
– speech, functional communication, cognitive status,
motor function and quality of life – were assessed with
regard to each performing art. In particular, speech and
functional communication outcomes were only assessed
in relation to singing interventions. Studies using sing-
ing interventions focused strongly on speech outcomes,
with comparatively few considering a wider range of
outcome domains. Furthermore, the volume of studies
differed substantially between performing arts modal-
ities. By far, the largest number of studies were
conducted on dance interventions (39 studies) followed
by singing interventions (12 studies). Comparably few
studies assessed music therapy (not singing-only) inter-
ventions (4 studies) and theatrical interventions (2
studies). Among dance interventions, the greatest
evidence was found for tango – either Argentine or
adapted tango – as well as PD-specific tango forms,
such as Dance for Parkinson’s Disease [80]. The body
of evidence is currently insufficient to determine
conclusively which performing arts modalities are most
effective for which specific outcome domains due to
the lack of comparative studies.
Meta-analysis results
Following assessment of feasibility (Additional file 1: Ap-
pendix 7, Part A), six meta-analysis sets could be ana-
lysed, including a total of ten unique studies. Tabulated
data for each comparison are shown in Additional file 1:
Appendix 7, Part B, and forest plots in Additional file 1:
Appendix 7, Part C.
The six feasible comparisons were: 1) UPDRS motor
for tango-based dance vs exercise (3 studies), 2) UPDRS
motor for tango-based dance vs usual care (2 studies), 3)
UPDRS motor for theatre vs physiotherapy (2 studies),
4) TUG for PD-specific dance vs usual care (2 studies),
5) TUG for tango-based dance vs exercise (2 studies)
and 6) PDQ-39 for PD-specific dance vs usual care (2
studies). Analyses were restricted to follow-up data
except for comparison #6 for which the analysis could
be conducted on change score data. The reason why
change score based analyses could not be conducted for
the other analysis sets was the unavailability of standard
deviation data for the difference between baseline and
follow-up scores for many studies, or a measure that
could be converted into a standard deviation.
In analysis set one, meta-analysis did not show any evi-
dence of a statistically significant difference in UPDRS
motor scores at follow-up between participants undertak-
ing tango-based dance and exercise (Z = 0.05, p = 0.96,
Additional file 1: Appendix 7, Part C), although there
were only three studies able to contribute to the meta-
analysis and heterogeneity was a concern (I2 = 57%). In
analysis set two, participants undertaking tango-based
dance were statistically significantly superior on UPDRS
motor at follow-up than participants undertaking exercise
(Z = 2.87, p = 0.004, Additional file 1: Appendix 7, Part
C), although there were only two studies and heterogen-
eity was a serious concern (I2 = 97%). In analysis set three,
there was no statistically significant difference in UPDRS
motor scores between participants undertaking theatrical
interventions or physiotherapy (Z = 0.37, p = 0.71, Add-
itional file 1: Appendix 7, Part C), although there were
only two studies. In analysis set four, there was no statisti-
cally significant difference in TUG between participants
undertaking PD-specific dance and usual care (Z = 0.98,
p = 0.33, Additional file 1: Appendix 7, Part C), although
there were only two studies and heterogeneity was a con-
cern (I2 = 64%). In analysis set five, participants undertak-
ing tango-based dance exhibited statistically significantly
superior TUG scores at follow-up than participants
undertaking exercise (Z = 11.25, p < 0.00001, Additional
file 1: Appendix 7, Part C, although there were only two
studies. In analysis set six, participants undertaking PD-
specific dance experienced statistically significantly super-
ior improvement in PDQ-39 from baseline to final
follow-up than participants undertaking usual care (Z =
3.77, p = 0.0002, Additional file 1: Appendix 7, Part C).
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Discussion
Summary
In relation to the first question of this review, the studies
reviewed indicate that group performing arts interven-
tions using active participation can impact positively on
some of the symptoms experienced by people with PD,
namely speech, cognition, motor function and quality of
life. Potentially related to the dominance of motor
features in the original conceptualisation of PD, [1] the
greatest volume of evidence relates to motor symptoms.
However, it is important to note this reflects that motor
symptoms have been studied more often, not necessarily
that the benefit of performing arts is greatest for this
outcome domain. The evidence for functional communica-
tion outcomes remains too limited to draw any conclusions.
In relation to the second review question, it is difficult
to assess which performing arts modalities are most ef-
fective for PD, either overall or in terms of improving
particular outcome domains, since there were no studies
comparing two or more different performing arts modal-
ities. Few studies had two active interventions of a per-
forming arts nature and where this was the case these
were limited to either different doses of the same inter-
vention or a comparison between two different dance
forms. The greatest volume of evidence was for dance
interventions. However, this shows that to date the
greatest research interest into performing arts for PD
has been in the modality of dance, not necessarily that it
is more effective than other performing art modalities. It
is difficult to compare performing arts modalities until
all outcome domains have been assessed for all perform-
ing arts modalities. Nevertheless, the evidence indicates
promise for all four performing arts modalities – dance,
music therapy, singing and theatre – that they could
benefit people with PD, at least in relation to certain
symptoms. Within dance, the greatest promise appears
to be with regard to tango and tango-related dance
forms, as well as PD-specific dance. One study [59]
showed a greater overall benefit of following than lead-
ing in tango dance for people with PD. This deserves
further study, as it could have implications for gender
equity in the clinical benefit offered by partnered dance
forms for PD.
Considering the results of the meta-analysis, which
must be interpreted with caution, of the six feasible
meta-analysis comparisons, which did not encompass
the full range of interventions, comparators and out-
come measures in the systematic review, three compari-
sons showed statistically significant differences, all in
favour of the performing arts arm. These were in ana-
lysis sets two, five and six. Participants undertaking
tango-based dance were shown to have superior UPDRS
motor and TUG scores than participants undertaking
exercise, while participants undertaking PD-specific
dance were shown to have superior PDQ-39 scores than
participants undertaking usual care.
Methodological considerations
The SURE checklists were used to appraise the quality
of each included study. These indicated that methodo-
logical limitations were frequent and some applied to
the majority of included studies.
Sample
There was a large variety in the locations of the studies in-
cluded, both with regard to the country of study as well as
the settings from which participants were recruited. This
has implications in terms of variation in terms of routine
clinical provision, but also in terms of societal familiarity
with specific performing art forms, and cultural views
both around performing arts and PD. Among performing
arts, dance in particular is gendered and conceptions and
norms relating to gender differ between cultures and
countries. In some cultures, despite men typically per-
forming the lead role in partnered dancing, there is a per-
sisting cultural view that dance is not a masculine pursuit,
[97] which is important to note given that men are at
around 50% elevated risk of developing PD compared to
women [98] and that therefore around 75% of people with
PD are male. Male participants tended to be under-
represented in the included studies (Additional file 1: Ap-
pendix 1), with many studies having a majority of female
participants. This limits the generalisability of findings re-
lating to performing arts interventions to male PD pa-
tients. Experiences and cultural meanings related to
cognitive impairment are not universal and can be
entwined with other contextual and cultural concepts
such as expectations of ageing [99]. Specifically in PD, the
psychological challenges of living with PD are closely
linked to socio-cultural concepts including shame and
stigma which differ between cultures and countries, [100]
while healthcare practitioners’ perceptions of facial ex-
pressions in PD are influenced by culture and gender, with
influence on perceptions of sociability and competence
[101]. These various cultural factors relevant to both PD
and the performing arts may exert a limiting influence on
the extent to which study findings can be extrapolated be-
yond the contexts in which they were studied. The wide
variability in sample sizes should also be taken into con-
sideration, and this was a key limiting factor on the ability
of many individual studies to draw more definitive conclu-
sions. Moreover, there was generally a lack of detail about
covariate structures in the statistical analysis and how this
may address sampling challenges.
Outcome measures
A large variety of outcomes were studied with a variety
of questionnaires and assessments used for the same
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construct. A wide variety of measures were used for
motor function. However, there were certain assess-
ments that featured frequently, such as the motor sub-
scale of the UPDRS, either in its original [96] or revised
version, [102] the Berg Balance Scale (BBS), [103] and
the Timed Up and Go test (TUG), [104] which improves
comparability between studies. Cognitive outcome mea-
sures used included the Mini Mental State Examination
(MMSE), [105] the Montreal Cognitive Assessment
(MoCA), [106] the Trail Making Test (TMT), [107] and
the Frontal Assessment Battery (FAB), [108] although
there was not a set of particular assessments that were
used across the majority of studies, making comparabil-
ity of cognitive results across studies difficult.
Studies assessing quality of life as a unitary concept
mainly used the PDQ-39, [86] although other assess-
ments such as the Oregon Health and Sciences Univer-
sity Quality of Life Scale [109] and the EuroQol-5D
quality of life tool [110] were occasionally used. Some
studies used other measures to assess more specific
aspects of quality of life, such as Voice-Related Quality
of Life (VRQoL) [88]. Studies assessing speech largely
focused on common phonatory, articulatory, intensity,
and intelligibility measures, although there were differ-
ences between studies in the exact ways these constructs
were measured as well as the specific speech materials
on which these measurements were made.
Only two studies assessed functional communication
and both used the Voice Handicap Index (VHI), [111] as
the outcome measure. While offering consistency, this
measure does not solely measure communicative partici-
pation, [112] which is an important limitation in the as-
sessment of functional communication since participation
is the final common pathway for many aspects of function
and disability [113]. Furthermore, any comparison of
speech and communication measures across studies in an
international systematic review faces intrinsic challenges
related to the cross-linguistic and cross-cultural elements
of this comparison since speech and communication are
closely tied to the specific language and cultural context.
While outcome assessments were typically validated in
the context in which they were developed, publications
did not usually state whether and how the instruments
had been validated in the country in which the study
took place. It is important to not only to ensure that the
translation is technically accurate, but that terms and
concepts used have appropriate cultural connotations in
order to avoid systematic differences in scoring at a
population level compared to the country in which the
instrument was originally developed. These issues are
also important to consider in cases where the language
is officially the same, but vocabulary and cultural concepts
can differ substantially, such as using an instrument devel-
oped in the USA in a British context. Moreover, there is
evidence, for example on quality of life questionnaires,
[114] that there is a lack of methodological standardisation
in the translation of outcome assessment tools. This may
limit the comparability of studies conducted in different
languages and countries. Additionally, one study offered
questionnaires in both English and French, [57] which
may restrict the internal validity of the outcome scores in
this study.
Allocation
Many studies were not randomised and studies differed
considerably in how they sampled participants, including
in some cases from ongoing performing arts groups for
PD in the community. The absence of randomisation
was justified by some studies on ethical grounds and also
for practical reasons, such as the availability of instruc-
tors in specific locations or during specific periods of
time. Pragmatic and observational approaches to study-
ing interventions may not be inferior [115]. While the
absence of randomisation may increase the risk of
confounding, especially if statistical adjustment methods
such as propensity-score matching are not used, it is im-
portant for trials to correspond closely to clinical prac-
tice especially with regard to the patient profile, else the
results may not able to be generalised to practice [116].
Some studies mention that assessors were blinded to
group allocation. It is not possible to blind participants
to the nature of the performing arts intervention that
they are receiving. Some studies mention that they did
not tell participants what the other group were receiving.
This may reduce bias but the ethical aspects of this
should also be considered.
Control groups
Less than half of studies included a control group and
those that did used a wide variety of comparator inter-
ventions broadly categorised as physiotherapy, exercise,
education, support groups, waiting list controls, music
appreciation, other arts, and usual care. In the study by
Tamplin et al., [48, 49] the control groups for the weekly
and monthly singing interventions undertook fundamen-
tally different activities from each other, making it
difficult to assess the relative effectiveness of the two
intervention frequencies. Usual care was the sole com-
parator in eleven studies, representing 41% of studies
that included a control group. According to Smelt et al.,
[117] usual care as a control group exhibits substantial
limitations and should be used with caution and de-
scribed in as much detail as the intervention. Although
descriptions of usual care were often adequate, it should
be noted that usual care for PD is an elusive, vague and
variant concept that may vary both between and within
countries due to health system differences and clinician
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preferences, so a clearly defined control intervention
may be preferable.
Intervention
Interventions were delivered by people from different dis-
ciplinary backgrounds and experience levels across studies
within a given performing arts modality. Theatrical inter-
ventions were all given by professional performers, while
music therapy interventions were all given (for those that
provided this information) by either music therapists or
music teachers. Greater variability in leaders was found in
singing and dance interventions. Singing interventions
were variously delivered by SLTs, music therapists, profes-
sional singing teachers, professional singers, recreational
singers, and trained students or other facilitators, while
the latter was variously delivered by professional dance in-
structors, professional dancers and recreational dancers,
with varying levels of experience with PD. Additionally,
there were studies in which all participants did not receive
the intervention from the same instructor or from instruc-
tors with equivalent backgrounds and experience. The
quality and focus of the intervention may have varied de-
pending on the experience, training, disciplinary back-
ground and methodological or theoretical focus of the
session leaders.
Limitations of the review
There were also certain limitations of the review process
that should be taken into consideration. The review
considered only English language literature. Secondly,
while screening, study selection and quality assessment
were conducted by two reviewers, only one researcher
designed and conducted the searches – due to available
expertise. Thirdly, only ten out of 56 included studies
could contribute to meta-analysis, which also could not
be conducted for all outcomes nor all combinations of
interventions and comparators. This meant that meta-
analysis could only form an additional analysis, and not
the primary analysis of the manuscript, which was the
narrative synthesis. Moreover, from six feasible analysis
sets for meta-analysis, five were restricted to an analysis
of follow-up data, due to non-availability of standard de-
viation data for the mean difference between baseline
and follow-up scores for most studies for which such a
change score was provided. Baseline differences between
arms were generally not statistically significant in the in-
cluded studies. However, any baseline differences, even
small, could impact upon the reliability of meta-analyses
in which solely follow-up data are compared.
Clinical implications
When considering interventions for people with PD, this
systematic review highlights the potential benefits of
group performing arts interventions involving active
participation, alongside appropriate pharmacotherapy. In
the absence of clear comparative evidence regarding
which performing arts modalities offer most benefit for
particular outcomes, while there is evidence that all of
dance, music therapy, singing and theatre may offer
certain benefits, patient preference and logistics may be
important considerations in terms of selecting which
performing arts modality to select. Additionally, singing
is the only modality so far that has been studied with
regarding to speech outcomes, so this should be taken
into consideration if patients’ particular concerns and
difficulties relate to speech. It is important to note that
suitable performing arts groups may already be available
in the community, and that directing patients to these
existing opportunities as a form of social prescribing,
[118] may help participants’ sense of social integration
as well as offering efficiencies in the health system organ-
isation. The limitations of the evidence base as outlined
above are also important to take into consideration.
Research implications
Further research is needed with greater methodological
rigour before firm conclusions can be drawn regarding
which particular performing arts modalities offer the
greatest benefits for people with PD and for which out-
comes. No studies compared different performing arts
modalities, for example a singing intervention with a
theatrical intervention. Future research could compare
these modalities through a combination of randomised
controlled trials as well as robust large-scale real-life ob-
servational studies, [115] potentially drawing on existing
PD performing arts classes that are offered in the com-
munity. With regard to trials, it is important that the de-
sign is well-matched to clinical need in order to ensure
that they can provide useful information for clinicians as
well as community service providers. While larger sam-
ples are important in future research, it is important that
this is not at the expense of high levels of participant
heterogeneity that could make the studies difficult to in-
terpret for practical benefit. Moreover, given the under-
representation of men in many studies, gender effects
require further study, especially with regard to dance,
due to the gendered nature of many dance forms. No
studies reported whether there were differential gender
effects of the intervention. One study [59] showed that
following in tango was overall more beneficial for people
with PD than leading. This could lead to partnered
dancing being more beneficial for women than men, if
dance follows traditional gender roles.
Moreover, there is a need to develop and agree standar-
dised outcome sets to increase comparability of studies.
The current review considered motor function, quality of
life, cognitive function, speech and functional communica-
tion, although future studies and reviews could consider
Barnish and Barran BMC Neurology          (2020) 20:371 Page 11 of 15
different outcome domains, including confidence and gen-
eralisation of skills. These would all benefit from consen-
sus on which assessment instruments to use. It could be
useful for all studies, irrespective of their primary focus, to
include a quality of life instrument. The PDQ-39, which
was the most commonly used quality of life instrument in
included studies in the current review, has been consid-
ered as probably the most appropriate health related
quality of life instrument in PD. [119] Greater focus on
participation would enrich the evidence base for the
current outcomes and others.
Participation is an important component of the World
Health Organization’s [120] International Classification of
Functioning, Disability, and Health (ICF), but has tradition-
ally not been a great focus of research in PD, although there
has been increased interest in recent years, which could be
further expanded in the years to come. Only two studies in
the current review assessed functional communication, des-
pite this being an area of particular priority for people with
PD. [24] This is an area of participation that in particular
requires considerable further study. Future studies could
use more modern outcome measures that are more focused
on communicative participation such as the Communica-
tive Participation Item Bank [121, 122] or the Communica-
tive Effectiveness Survey [123, 124]. Indeed, communicative
participation itself is a complex concept that is believed to
be influenced by a range of PD-related factors including
level of cognitive impairment, [125, 126] so would benefit
from further study from a range of perspectives including
in the context of performing arts interventions.
Moreover, future research and evidence syntheses
should seek to address a wider range of outcomes relating
to the potential benefit of performing arts interventions
on outcomes in PD beyond clinical effectiveness. These
outcomes could include adverse events, tolerability,
participant experiences of the interventions, and the cost
effectiveness of performing arts interventions for PD.
Conclusion
Here we present the first systematic review to assess the
potential benefit of all performing arts intervention mo-
dalities for people with PD. The results of this review
highlight the potential positive use of group performing
arts interventions – dance, music therapy, singing and
theatre – with active participation for speech, motor
function, cognition and quality of life in PD. However,
methodological limitations, in particular the lack of
studies comparing different performing arts modalities,
make it difficult to conclude definitively which perform-
ing arts modalities offer the most benefit for people with
PD, and whether different modalities are most beneficial
for different outcome domains. The evidence regarding
functional communication outcomes remains too limited
to draw conclusions.
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